Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma

被引：47

作者：

Khoury, JD

Rassidakis, GZ

Medeiros, LJ

Amin, HM

Lai, R

机构：

[1] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2B7, Canada

[2] Cross Canc Inst, Walter Mackenzie Hlth Sci Ctr 4B1, Edmonton, AB T6G 2B7, Canada

来源：

BLOOD | 2004年 / 104卷 / 05期

关键词：

D O I：

10.1182/blood-2004-03-1151

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1580 / 1581

页数：2

共 10 条

[1] Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma
Amin, HM
Medeiros, LJ
Ma, Y
Feretzaki, M
Das, P
Leventaki, V
Rassidakis, GZ
O'Connor, SL
McDonnell, TJ
Lai, R
[J]. ONCOGENE, 2003, 22 (35) : 5399 - 5407
[2] AMIN HM, 2004, MODERN PATHOL, V17, pA238
[3] [Anonymous], WHO CLASSIFICATION T
[4] Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
Catlett-Falcone, R
Landowski, TH
Oshiro, MM
Turkson, J
Levitzki, A
Savino, R
Ciliberto, G
Moscinski, L
Fernández-Luna, JL
Nuñez, G
Dalton, WS
Jove, R
[J]. IMMUNITY, 1999, 10 (01) : 105 - 115
[5] SOCS1 and SHP1 hypermethylation in multiple myeloma:: implications for epigenetic activation of the Jak/STAT pathway
Chim, CS
Fung, TK
Cheung, WC
Liang, R
Kwong, YL
[J]. BLOOD, 2004, 103 (12) : 4630 - 4635
[6] Translocations involving anaplastic lymphoma kinase (ALK)
Duyster, J
Bai, RY
Morris, SW
[J]. ONCOGENE, 2001, 20 (40) : 5623 - 5637
[7] Khoury JD, 2003, CLIN CANCER RES, V9, P3692
[8] Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation
Koyama, M
Oka, T
Ouchida, M
Nakatani, Y
Nishiuchi, R
Yoshino, T
Hayashi, K
Akagi, T
Seino, Y
[J]. LABORATORY INVESTIGATION, 2003, 83 (12) : 1849 - 1858
[9] Oka T, 2002, CANCER RES, V62, P6390
[10] Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
Zamo, A
Chiarle, R
Piva, R
Howes, J
Fan, Y
Chilosi, M
Levy, DE
Inghirami, G
[J]. ONCOGENE, 2002, 21 (07) : 1038 - 1047

← 1 →